Created at	Source	Raw Value	Validated value
Oct. 26, 2020, 8:29 a.m.	oms	Outcome name:rate of development of serious adverse eventsMeasure:Serious adverse events related to transfusion of convalescent plasmaTimepoints:6 months	Outcome name:rate of development of serious adverse eventsMeasure:Serious adverse events related to transfusion of convalescent plasmaTimepoints:6 months